- Oral Devices Mandibular Advancement Devices (MADS)
- Tongue-Retaining Devices (TRDS)
- Nasal Dilator, Chin Strap
- Position Control
- Tongue Stabilizing Devices
- Expiratory Positive Airway Pressure
| 1. Executive Summary |
| 2. U.S. Anti-Snoring Devices and Snoring Surgery Market Introduction |
| 2.1. U.S. Anti-Snoring Devices and Snoring Surgery Market Taxonomy |
| 2.2. U.S. Anti-Snoring Devices and Snoring Surgery Market Definitions |
| 2.2.1. Device |
| 2.2.2. Surgical Procedure |
| 2.2.3. Distribution Channel |
| 3. U.S. Anti-Snoring Devices and Snoring Surgery Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. U.S. Anti-Snoring Devices and Snoring Surgery Market Dynamic Factors - Impact Analysis |
| 3.6. U.S. Anti-Snoring Devices and Snoring Surgery Market Competition Landscape |
| 4. U.S. Anti-Snoring Devices and Snoring Surgery Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. U.S. Anti-Snoring Devices and Snoring Surgery Market Forecast, By Device, 2019 - 2023 and Forecast, 2024 - 2030 |
| 5.1. Oral Devices |
| 5.1.1. Mandibular Advancement Devices (MADS) |
| 5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Tongue-Retaining Devices (TRDS) |
| 5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.2. Nasal Dilator |
| 5.2.1. External Nasal Dilators (Nasal Strips) |
| 5.2.2. Other Nasal Devices (Nasal Stents, Nasal Clips, and Septal Stimulators) |
| 5.3. Chin Strap |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Position Control |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Tongue Stabilizing Devices |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Expiratory Positive Airway Pressure |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. U.S. Anti-Snoring Devices and Snoring Surgery Market Forecast, By Surgical Procedure, 2019 - 2023 and Forecast, 2024 - 2030 |
| 6.1. Uvulopalatopharyngoplasty |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Pillar Procedure |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Laser-Assisted Uvulopalatoplasty |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Radiofrequency Ablation |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Sclerotherapy |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Septoplasty |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Palatal Stiffening Procedures |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Injection Snoreplasty/Sclerotherapy |
| 6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 6.9. U.S. Anti-Snoring Devices and Snoring Surgery Market - Opportunity Analysis Index, By Device, By Surgery, By Distribution Channel, and Region, 2024 - 2030 |
| 7. U.S. Anti-Snoring Devices and Snoring Surgery Market Forecast, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2030 |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinics |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. U.S. Anti-Snoring Devices and Snoring Surgery Market - Opportunity Analysis Index, By Device, By Surgery, By Distribution Channel, and Region, 2022 2028 |
| 9. Competition Landscape |
| 9.1. Strategic Dashboard of Top Market Players |
| 9.2. Company Profiles (Introduction, Financial Analysis, Feedstock Material & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 9.2.1. Pure Sleep Company |
| 9.2.2. Airway Management Inc. |
| 9.2.3. Biotronik Se & Co. Kg |
| 9.2.4. Recent Developments |
| 9.2.5. Meditas Ltd |
| 9.2.6. Sleeping Well, LLC |
| 9.2.7. Somnomed Limited |
| 9.2.8. The Pure Sleep Company |
| 9.2.9. Tomed Dr. Toussaint Gmbh |
| 9.2.10. Apnea Sciences Corporation |
| 9.2.11. Theravent, Inc. |
| 9.2.12. Glaxosmithkline, PLC |
| 10. Research Methodology |
| 11. Key Assumptions and Acronyms |
Us Anti Snoring Devices And Snoring Surgery Market Segmentation
By Device
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
The U.S. anti-snoring devices and snoring surgery market key players are the Pure Sleep Company, Airway Management Inc., Biotronik Se & Co. Kg, Recent Developments, Meditas Ltd, Sleeping Well, LLC, Somnomed Limited, The Pure Sleep Company, Tomed Dr. Toussaint Gmbh, Apnea Sciences Corporation, Theravent, Inc., Glaxosmithkline, PLC
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
- Pure Sleep Company
- Airway Management Inc.
- Biotronik Se & Co. Kg
- Recent Developments
- Meditas Ltd
- Sleeping Well, LLC
- Somnomed Limited
- The Pure Sleep Company
- Tomed Dr. Toussaint Gmbh
- Apnea Sciences Corporation
- Theravent, Inc.
- Glaxosmithkline, PLC